Cargando…

Infliximab Trough Levels and Quality of Life in Patients with Inflammatory Bowel Disease in Maintenance Therapy

OBJECTIVE: Investigate the association between infliximab trough levels and quality of life in inflammatory bowel disease patients in maintenance therapy. METHODS: We carried out a transversal study with inflammatory bowel disease patients in infliximab maintenance therapy. Infliximab trough levels...

Descripción completa

Detalles Bibliográficos
Autores principales:	Parra, Rogério S., Feitosa, Marley R., Ribeiro, Letícia C. H., Castro, Lais A., Rocha, José J. R., Féres, Omar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964568/ https://www.ncbi.nlm.nih.gov/pubmed/29853857 http://dx.doi.org/10.1155/2018/1952086

Ejemplares similares

Infliximab-associated fulminant hepatic failure in ulcerative colitis: a case report
por: Parra, Rogerio Serafim, et al.
Publicado: (2015)

Serum-Infliximab Trough Levels in 45 Children with Inflammatory Bowel Disease on Maintenance Treatment
por: Rolandsdotter, Helena, et al.
Publicado: (2017)

Rate of conversion to an open procedure: Is it really reduced in robotic colorectal surgery?
por: Parra, Rogério Serafim, et al.
Publicado: (2021)

COVID-19 quarantine measures are associated with negative social impacts and compromised follow-up care in patients with inflammatory bowel disease in Brazil
por: Feitosa, Marley Ribeiro, et al.
Publicado: (2021)

Postoperative Complications and Stoma Rates After Laparoscopic Resection of Deep Infiltrating Endometriosis with Bowel Involvement
por: Parra, Rogério Serafim, et al.
Publicado: (2022)

Treatment of acute severe ulcerative colitis using accelerated infliximab regimen based on infliximab trough level: A case report
por: Garate, Ana Lorena Sousa de Vasconcelos, et al.
Publicado: (2021)

Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease
por: Sekhri, Shaina, et al.
Publicado: (2021)

Clinical Use of Measuring Trough Levels and Antibodies against Infliximab in Patients with Pediatric Inflammatory Bowel Disease
por: Choi, So Yoon, et al.
Publicado: (2017)

Serum Infliximab Cutoff trough Level Values for Maintaining Hematological Remission in Pediatric Inflammatory Bowel Disease
por: Choi, So Yoon, et al.
Publicado: (2019)

Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
por: Theodoraki, Eirini, et al.
Publicado: (2021)

Spontaneous transvaginal small bowel evisceration: a case report
por: Parra, Rogério Serafim, et al.
Publicado: (2010)

Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-making for IBD Outpatients on Maintenance Infliximab Therapy
por: Huang, Vivian W., et al.
Publicado: (2015)

Laparoscopic bowel resection of deep infiltrating endometriosis. Comparative outcomes of a public teaching hospital and a referral private hospital
por: Parra, Rogério Serafim, et al.
Publicado: (2020)

Surgical and postoperative evaluations of rectal adenomas excised with a rigid proctoscope
por: de Lima, Roberta Denise Alkmin Lopes, et al.
Publicado: (2020)

Efficacy of Infliximab Biosimilar for Maintenance Therapy in Pediatric Inflammatory Bowel Disease Following Infliximab Originator
por: Hinshaw, Amie, et al.
Publicado: (2022)

High infliximab trough concentrations are associated with sustained histologic remission in inflammatory bowel disease: a prospective cohort study
por: Wilson, Aze, et al.
Publicado: (2021)

Leukocytoclastic Vasculitis Secondary to Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Diseases: A Multicenter Retrospective Cohort Study
por: Parra, Rogério Serafim, et al.
Publicado: (2023)

Hyperbaric oxygen therapy decreases mortality due to Fournier’s gangrene: a retrospective comparative study
por: Féres, Omar, et al.
Publicado: (2021)

A Novel Severity Score Index for Febrile Neutropenic Patients with Colorectal Diseases
por: Perazzoli, Camila, et al.
Publicado: (2019)

Retrospective analysis of surgical and oncological results of laparoscopic surgeries performed by residents of coloproctology
por: MOTA, BÁRBARA BIANCA LINHARES, et al.
Publicado: (2023)

Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?
por: Teixeira, Fabio Vieira, et al.
Publicado: (2019)

Infliximab trough level combined with inflammatory biomarkers predict long-term endoscopic outcomes in Crohn’s disease under infliximab therapy
por: Cao, Wan-Ting, et al.
Publicado: (2022)

Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
por: Oh, Eun Hye, et al.
Publicado: (2017)

Infliximab in inflammatory bowel disease
por: Papamichael, Konstantinos, et al.
Publicado: (2019)

Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil
por: Parra, Rogerio S, et al.
Publicado: (2019)

Model Informed Precision Dosing Tool Forecasts Trough Infliximab and Associates with Disease Status and Tumor Necrosis Factor-Alpha Levels of Inflammatory Bowel Diseases
por: Primas, Christian, et al.
Publicado: (2022)

Access to High-Cost Biological Agents: Perceptions of Brazilian Patients with Inflammatory Bowel Diseases
por: Parra, Rogerio Serafim, et al.
Publicado: (2023)

Adjunctive Hyperbaric Oxygen Therapy in Refractory Crohn's Disease: An Observational Study
por: Feitosa, Marley R., et al.
Publicado: (2021)

PPARG expression in colorectal cancer and its association with staging and clinical evolution (1)
por: Villa, Andre Luiz Prezotto, et al.
Publicado: (2020)

Preservation of the superior rectal artery in laparoscopic colectomy for slow transit constipation: Is it really associated with better outcomes?
por: Parra, Rogério Serafim, et al.
Publicado: (2021)

Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn’s Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab
por: Sorrentino, Dario, et al.
Publicado: (2015)

Cytokine Profile at Diagnosis Affecting Trough Concentration of Infliximab in Pediatric Crohn’s Disease
por: Kwon, Yiyoung, et al.
Publicado: (2022)

Inflammatory bowel disease of the lung: The role of infliximab?()
por: Hayek, Adam J., et al.
Publicado: (2015)

Infliximab trough levels are associated with endoscopic healing but not with transmural healing at one year treatment with infliximab in pediatric patients with Crohn’s disease
por: Choi, So Yoon, et al.
Publicado: (2023)

Hyperbaric oxygen therapy ameliorates TNBS-induced acute distal colitis in rats
por: Parra, Rogério S, et al.
Publicado: (2015)

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
por: van der Maas, Aatke, et al.
Publicado: (2012)

Vedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel Disease
por: Vaughn, Byron P., et al.
Publicado: (2020)

Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease
por: Kato, Masaichi, et al.
Publicado: (2021)

Management of inflammatory bowel disease in poor responders to infliximab
por: Guerra, Iván, et al.
Publicado: (2014)

Clinical and Immunological Factors Associated with Recommended Trough Levels of Adalimumab and Infliximab in Patients with Crohn’s Disease
por: Orts, Beatriz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_082i43nvbocoepubojrkn5reao